RetinalGenix Technologies (RTGN) Accounts Payables (2020 - 2026)

RetinalGenix Technologies (RTGN) has 7 years of Accounts Payables data on file, last reported at $1.2 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables rose 28.83% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (up 28.83% YoY), and the FY2025 full-year result was $1.1 million, up 17.64% from the prior year.
• Accounts Payables grew to $1.2 million in Q1 2026, from $1.1 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $1.2 million in Q1 2026 to a low of $262467.0 in Q1 2022.
• A 5-year average of $773379.6 and a median of $862453.0 in 2024 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables surged 141.62% in 2023 and increased 4.2% in 2024, its largest moves.
• Tracing RTGN's Accounts Payables over 5 years: stood at $475480.0 in 2022, then soared by 86.11% to $884920.0 in 2023, then climbed by 4.2% to $922083.0 in 2024, then climbed by 17.64% to $1.1 million in 2025, then climbed by 9.66% to $1.2 million in 2026.
• Business Quant data shows RTGN's Accounts Payables at $1.2 million in Q1 2026, $1.1 million in Q4 2025, and $1.0 million in Q3 2025.